Johnson & Johnson – Page 3

Johnson & Johnson Reaches $8.9 Billion Talc Settlement

The company faces a flood of lawsuits claiming its talc products caused cancer. The proposed settlement requires approval by a bankruptcy court, but has the backing of plaintiffs’ lawyers.

By Tiffany Hsu

Coronavirus (2019-nCoV) Drugs (Pharmaceuticals) Gavi, the Vaccine Alliance Johnson & Johnson Moderna Inc Novavax Inc Serum Institute of India Third World and Developing Countries Vaccination and Immunization

Covid Vaccine Makers Kept Prepayments for Canceled Shots for Poor Nations

Separately, Johnson & Johnson is demanding additional payment for unwanted shots, confidential documents show.

By Stephanie Nolen and Rebecca Robbins

Cancer Decisions and Verdicts Hazardous and Toxic Substances Johnson & Johnson Suits and Litigation (Civil)

Johnson & Johnson’s Talc-Related Bankruptcy Filing Is Rejected

The company faces some 40,000 plaintiffs that claim its baby powder caused cancer.

By Isabella Simonetti

Drugs (Pharmaceuticals) Europe Gender Janssen Pharmaceutica Johnson & Johnson North America South America Vaccination and Immunization Viruses

The Only H.I.V. Vaccine in Advanced Trials Has Failed. What Now?

Janssen Pharmaceuticals ended a global trial after independent experts determined the vaccine was not effective. But there are other possibilities in the pipeline, scientists said.

By Apoorva Mandavilli

mosaec